TrialThe European journal of health economics : HEPAC : health economics in prevention and care2018

The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England.

Yang Meng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.